This functionality is implemented using Javascript. It cannot work without it, etc...

We are loading the information...

Skip to main content

Medical Policies

Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.

Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.

ID Title Last Review Next Review Description Access
08.001.031 Chemical Peels Jan 12, 2024 Jan 20, 2025 Dermal chemical peels used to treat individuals with numerous (>10) actinic keratoses or other premalignant... View
08.001.033 Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome Feb 08, 2024 Feb 20, 2025 Multiple myeloma a single or second (salvage) autologous hematopoietic cell transplantation may be... View
08.001.034  DYSPHAGIA THERAPY  Feb 14, 2024 Oct 20, 2024 Therapy for the treatment of dysphagia is considered medically necessary and proceeds for payment when any... View
08.001.035 Aquatic Therapy Nov 11, 2020 Policy Archived Aquatic therapy to improve or restore physical function after illness, trauma or physical damage or loss of... View
08.001.036 Allogeneic Hematopoietic Cell Transplantation Feb 12, 2024 Feb 20, 2025 Allogeneic hematopoietic cell transplantation (hct) using a myeloablative conditioning regimen may be... View
08.001.037 Hematopoietic Cell Transplantation for Hodgkin Lymphoma Feb 12, 2024 Feb 20, 2025 Autologous hematopoietic cell transplantation (hct) may be considered medically necessary in patients with... View
08.001.038 Radio 223 Injection (Xofigo) Nov 10, 2021 Policy Archived The radium 223 injection (xofigo) is considered for payment when all of the following criteria for prostate... View
08.001.039 Extracorporeal Membrane Oxygenation for Adult Conditions Jun 12, 2024 Jun 20, 2025 The use of extracorporeal membrane oxygenation (ecmo) may be considered medically necessary for the... View
08.001.040 Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis Dec 16, 2019 Policy Archived The identification and subsequent treatment of chronic cerebrospinal venous insufficiency in patients with... View
08.001.041 Application Of Fluoride (Varnish) Nov 14, 2019 Policy Archived Fluoride varnish is considered medically necessary to help reduce the risk of decayed, missing, or filled... View
08.001.042 Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used With Autologous Bone Marrow) Feb 20, 2024 Feb 20, 2025 Mesenchymal stem cell therapy is considered investigational for all orthopedic applications, including use in... View
08.001.043 Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia Feb 12, 2024 Feb 20, 2025 Childhood acute lymphoblastic leukemia autologous or allogeneic hematopoietic cell transplantation... View
08.001.044 Treatment of Hyperhidrosis Jul 19, 2024 Jul 20, 2025 Treatment of primary focal hyperhidrosis using aluminum chloride 20% solution, botulinum toxin for severe... View
08.001.045 Cranial Electrotherapy Stimulation and Auricular Electrostimulation Mar 15, 2024 Mar 20, 2025 Cranial electrotherapy stimulation (also known as cranial electrostimulation therapy) is investigational in... View
08.001.046 Electronic Brachytherapy for Nonmelanoma Skin Cancer Aug 15, 2023 Aug 20, 2024 Electronic brachytherapy for the treatment of nonmelanoma skin cancer is... View
08.001.047 Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Feb 12, 2024 Feb 20, 2025 Allogeneic hematopoietic cell transplantation is considered medically necessary to treat chronic lymphocytic... View
08.001.048 Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas Feb 12, 2024 Feb 20, 2025 For individuals with non-hodgkin lymphoma (nhl) b-cell subtypes considered aggressive (except mantle cell... View
08.001.049 Hematopoietic Cell Transplantation for Autoimmune Diseases Feb 20, 2024 Feb 20, 2025 Autologous or allogeneic hematopoietic cell transplantation (hct) is considered investigational as a... View
08.001.050 Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Feb 20, 2024 Feb 20, 2025 Allogeneic hematopoietic cell transplantation (hct) using a myeloablative conditioning regimen may be... View
08.001.051 Hematopoietic cell Transplantation for Primary Amyloidosis Feb 13, 2024 Feb 20, 2025 Autologous hematopoietic cell transplantation may be considered medically necessary to treat primary... View

Want to be up to date on topics like health, trending news, useful tips, lifestyles and more?

Subscribe to our blog and don't miss out on anything!

Subscribe to the blog

We want to personalize the content according to your preferences

Please select one or more categories to continue

Thanks for subscribing!

You will receive information of interest in your email.

787-277-6653 787-474-6326